Valeo Financial Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$19.4 - $27.42 $4,481 - $6,334	-231 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$25.02 - $54.99 $4,128 - $9,073	165 Added 250.0%	231 $6,000
Q3 2020 Oct 28, 2020	BUY	$36.42 - $57.0 $2,403 - $3,762	66 New	66 $3,000
Q2 2019 Jul 10, 2019	SELL	$23.32 - $28.12 $23,320 - $28,120	-1,000 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$16.17 - $27.38 $16,170 - $27,380	1,000 New	1,000 $27,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.